| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | REGENCY CENTERS CORPORATION | Mar 24, 2023 | |
| Buy | REGENCY CENTERS CORPORATION | Aug 23, 2022 | |
| Buy | REGENCY CENTERS CORPORATION | Jun 27, 2022 | |
| Buy | RENAISSANCERE HOLDINGS LTD | May 27, 2021 | |
| Buy | RENAISSANCE HOLDINGS LTD | May 27, 2021 | |
| Buy | Regency Centers Corporation | Nov 29, 2020 | |
| Sell | Regency Centers Corporation | Oct 29, 2020 | |
| Buy | Regency Centers Corporation | Mar 25, 2020 | |
| Buy | REGIS CORP | Apr 2, 2018 | |
| Sell | REGAL ENTERTAINMENT GROUP CL | Feb 14, 2018 |
This page tracks congressional stock trading activity in Regencell Bioscience Holdings Limited (RGC) in the Healthcare sector. Disclosed Capitol has indexed 27 disclosed congressional trades involving RGC. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of April 2023 — Disclosed Capitol has tracked 27 disclosed congressional trades in Regencell Bioscience Holdings Limited (RGC) — 13:10 sell-heavy ratio — led by Jim Renacci (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Mar 24, 2023 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| Aug 23, 2022 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Jun 27, 2022 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| May 27, 2021 | Diana Harshbarger | R | Purchase | $1,001 - $15,000 |
| May 27, 2021 | Diana Harshbarger | R | Purchase | $1,001 - $15,000 |
| Nov 29, 2020 | Tom Malinowski | D | Purchase | $15,001 - $50,000 |
| Oct 29, 2020 | Tom Malinowski | D | Sale | $15,001 - $50,000 |
| Mar 25, 2020 | Tom Malinowski | D | Purchase | $15,001 - $50,000 |
| Apr 2, 2018 | Michael McCaul | R | Purchase | $1,001 - $15,000 |
| Feb 14, 2018 | Jim Renacci | R | Exchange | $1,001 - $15,000 |
Across the 27 disclosed congressional trades in Regencell Bioscience Holdings Limited (RGC), members of Congress have reported 10 buys and 13 sells. The average 30-day alpha vs. the S&P 500 is 3.23%.